Ginipral konts. for solution for inf. 25mkg/5ml amp. 5 ml No. 5

concentrate for solution for infusions Ginipral is applied to short-term treatment of an uncomplicated course of premature births:

• oppression of sokratitelny uterine activity at patients with the duration of gestation from 22 to 37 weeks in the absence of medical or gynecologic contraindications to performing tokolitichesky therapy.
• before version from cross situation.
• as an emergency measure at premature births before transportation of the pregnant woman in hospital.

Structure

Active ingredient: hexoprenaline;

1 ampoule of 5 ml contains 0.025 mg of a hexoprenalin of sulfate;

Excipients: sodium metabisulphite (E 223) dinatrium edetat; sodium chloride, acid sulfuric, divorced (for adjustment rn) water for injections.

Contraindication

• Hypersensitivity to a hexaprenalin or to any component of drug.
• Presence of any disease up to 22 weeks of pregnancy.
• medicament Use as tokolitichesky means to patients with coronary heart disease in the anamnesis or to patients with essential risk factors of developing coronary heart disease.
• Threat of an abortion at the I and II trimesters of pregnancy.
• Any disease of mother or a fruit at which preservation of pregnancy is dangerous, for example, heavy degree of a toxaemia, a pre-natal infection, vaginal bleeding owing to placental presentation, an eclampsia or a heavy preeclampsia, placental detachment or compression of an umbilical cord.
• Pre-natal death of a fruit, lethal congenital anomalies in the anamnesis or lethal chromosomal anomalies.
• Bronchial asthma with hypersensitivity to sulfates.
• Disease of a cardiovascular system, in particular tachyarrhythmia, myocarditis, defect of the mitral valve.
• Hyperthyroidism.
• Serious illness of a liver and kidneys.
• Glaucoma.

Route of administration

For jet introduction or infusion.

Specified dosage can be applied only as approximate as the tocolysis demands individual approach to the patient.

. Treatment is carried out only in correctly equipped institutions for implementation of constant control behind the state of health of mother and a fruit.

Pregnant women

by

Feature of use

by

for use for children.

Drivers

Drug has no

or has insignificant influence on speed of response at control of motor transport or other mechanisms.

Overdose

Symptoms of overdose can be

: substantial increase of heart rate at the woman, a tremor, heartbeat, a headache, perspiration.

Usually for elimination of these symptoms the reduction of a dosage of medicament is enough

. For elimination of heavy symptoms of overdose the use of non-selective beta blockers which competitively inhibit effect of the medicament Ginipral is recommended.

Side effects

Most widespread side effects of the medicament Ginipral connected with pharmacological properties of beta-adrenergic agonists. For the purpose of elimination or reduction of emergence of undesirable effects careful control of a hemodynamics, such as arterial blood pressure, heart rate and the corresponding correction of a dose of medicament carry out. These effects usually disappear after medicament phase-out.

Interaction

Drug Ginipral should not be used together with the medicaments containing ergot alkaloids and also with drugs, calciferous, vitamin D, Dihydrotachysterolum and mineralokortikoida.

to Store

in original packing at a temperature not above 25 °C.

to Store

out of children's reach!

Expiration date - 3 years.